Abstract
PLATELET activation by the coagulation protease thrombin is central to arterial thrombosis, a major cause of morbidity and mortality. We recently isolated a complementary DNA encoding the platelet thrombin receptor. The extracellular amino-terminal extension of this seven transmembrane domain receptor contains the putative thrombin cleavage site LDPR/S which is critical for receptor activation. By replacing this cleavage site with the cleavage site for enterokinase, we have created a functional enterokinase receptor. This result demonstrates that all information necessary for receptor activation is provided by receptor proteolysis. Nanomolar enterokinase concentrations are required to activate this new receptor, in contrast to the picomolar thrombin concentrations that activate wild-type thrombin receptor. We identified a receptor domain critical for thrombin's remarkable potency at its receptor. This domain resembles the carboxyl tail of the leech anticoagulant hirudin and functions by binding to thrombin's anion-binding exosite. Our studies thus define a model for thrombin–receptor interaction. The utility of this model was demonstrated by the design of novel thrombin inhibitors based on receptor peptides.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vu, T.-K. H., Hung, D. T., Wheaton, V. I. & Coughlin, S. R. Cell 64, 1057–1068 (1991).
Light, A. & Janska, H. Trends biochem. Sci. 14, 110–112 (1989).
Bode, W. et al. EMBO J. 8, 3467–3475 (1989).
Jakubowski, J. A. & Maragonore, J. M. Blood 75, 399–406 (1990).
Rydel, T. J. et al. Science 249, 277–280 (1990).
Mao, S. J., Yates, M. T., Owen, T. J. & Krstenansky, J. L., Biochemistry 27, 8170–8173 (1988).
Krstenansky, J. L., Owen, T. J., Yates, M. T. & Mao, S. J. J. med. Chem. 30, 1688–1691 (1987).
Liu, L.-W., Vu, T.-K. H., Esmon, C. T. & Coughlin, S. R. J. biol. Chem. (in the press).
Kunkel, T. A., Roberts, J. D. & Zakour, R. A. Meth. Enzym. 154, 367–382 (1987).
Sanger, F., Niklen, S. & Coulson, A. R. Proc. natn. Acad. Sci. U.S.A. 74, 5463–5467 (1977).
Biggs, R. Haemostasis and Thrombosis 2nd edn 722 (Blackwell Scientific, Oxford, 1976).
Niehrs, C., Huttner, W. B., Carvallo, D. & Degryse, E. J. biol. Chem. 265, 9314–9318 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vu, TK., Wheaton, V., Hung, D. et al. Domains specifying thrombin–receptor interaction. Nature 353, 674–677 (1991). https://doi.org/10.1038/353674a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/353674a0
This article is cited by
-
Beyond thrombosis: the impact of tissue factor signaling in cancer
Journal of Hematology & Oncology (2020)
-
G12/13 is activated by acute tethered agonist exposure in the adhesion GPCR ADGRL3
Nature Chemical Biology (2020)
-
Protease-activated receptors (PARs): mechanisms of action and potential therapeutic modulators in PAR-driven inflammatory diseases
Thrombosis Journal (2019)
-
Trans-fused 5-[(tert-Butoxtycarbonyl)amino]octahydroindenes as a protease activated receptor-1 (PAR1) antagonist
Archives of Pharmacal Research (2016)
-
Octahydrocyclopenta[c]pyridine and octahydrocyclopenta[c]pyran analogues as a protease activated receptor 1 (PAR1) antagonist
Archives of Pharmacal Research (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.